Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001856744-26-000001
Filing Date
2026-03-04
Accepted
2026-03-04 17:31:22
Documents
1
Period of Report
2026-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772663480.html 4  
1 FORM 4 wk-form4_1772663480.xml 4 4407
  Complete submission text file 0001856744-26-000001.txt   5959
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 201 INDUSTRIAL RD. #310 SAN CARLOS CA 94070
Business Address
Sankar Subramanian (Reporting) CIK: 0001856744 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 26722950